The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...
Eli Lilly’s (LLY) blood cancer (leukemia) treatment called Jaypirca has shown promising results in a clinical trial. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, ...
Sept 8 (Reuters) - Eli Lilly's (LLY.N), opens new tab approved blood cancer therapy Jaypirca helped delay progression of the disease in previously untreated patients in a late-stage study, advancing ...
Acute lymphoblastic leukemia is an aggressive cancer in the blood and bone marrow, with around 800 people being diagnosed in the UK every year, around half of which are in adults. Data shows patients ...
Omeros Corporation (NASDAQ:OMER) on Thursday established the Omeros Oncology Clinical Steering Committee to advance Omeros’ OncotoX biologics program focused on acute myeloid leukemia (AML). AML is ...
CURE spoke with chief medical officer Gwen Nichols and partner Suleika Jaouad about the inclusive rebranding. The Leukemia and Lymphoma Society, a nonprofit organization that aims to cure blood cancer ...
Jason Weiner has benefited from the opportunity to participate in a myelofibrosis clinical trial at MSK. He is shown here with his wife, Cori, children Dominik, Kasia, and Damian, and dog Babka around ...
GSK finally has the long-awaited FDA approval it sought for blood cancer drug Blenrep. Three years after the pharmaceutical giant pulled the multiple myeloma therapy from the market, the FDA approved ...
Light the Night. (Copyright 2024 by KSAT - All rights reserved.) SAN ANTONIO – The organization behind the annual Light the Night event may have changed its name ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback